Xconomy

JULY 17, 2020

In the second quarter, 16 of the top 25 largest early-stage venture capital deals were investments in life science companies. The figures come from the National Venture Capital Association and financial research firm Pitchbook.

Venture Capital 90

Venture Capital Invest Research Capital 90

Xconomy

JANUARY 27, 2020

By month’s end, five more are anticipated to join the class of 2020 initial public offerings—and four of those are in life sciences, according to IPO research firm Renaissance Capital. So far this year four privately held companies have made the transition to trading on the public markets.

Westlake Village 109

Westlake Village Class Research Capital 109

Xconomy

JUNE 26, 2020

IPO research firm Renaissance Capital says it anticipates—what else—a “renaissance” in the public markets come third quarter. Once considered all but shuttered, the IPO market again saw an active week between new public debuts and more companies joining the queue.

News 104

News Activity Research Marketing 104

Both Sides of the Table

MAY 6, 2015

There are so many great, young funds in the market and many of them are attracting LP capital. To mark the occasion of launching this inaugural report I am also proud to announce that we’ve also launched the Upfront Insights blog. It will also serve as home to our partner blogs and to our company announcements.

Marketing 150

Marketing Newsletter Venture Capital Blogging 150

Startup Professionals Musings

AUGUST 22, 2021

Consumers are doing their own research and don’t want to engage a pushy salesperson or message. Inbound data, including site page visits, blog reads, and actual orders linked to content are much more relatable to return-on-investment than email blasts, sound-bites delivered, and TV show ratings. Marty Zwilling.

Customer 172

Customer Custom Marketing Social Media 172

From the Venture Trenches

APRIL 19, 2013

Henry Blodget , was once the darling of Wall Street covering Internet securities at Merrill Lynch’s and reporting on businesses such as Infospace, Internet Capital Group and Amazon. In 2002 Blodget’s salary was $12 million. In 2003 Blodget struck a civil settlement deal with the SEC that cost him $4 million.

Blogging 45

Blogging News Journal Invest 45

Xconomy

JUNE 20, 2019

So far this year, 72 companies have gone public, according to IPO research firm Renaissance Capital. It’s been a strong year for biotech IPOs and Wednesday shaped up to be a particularly busy day as four life science firms debuted on the public markets. That total is down 20 percent compared to the same period a year ago.

Research 108

Research Activity Capital Marketing 108

Xconomy

MAY 9, 2019

According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. Five biotechs priced their IPOs and at least one more is coming. Just as last year, healthcare IPOs lead the way.

Pricing 110

Pricing Research Capital Marketing 110

Startup Professionals Musings

APRIL 2, 2022

Most consumers now research online product reviews, blogs, YouTube, Twitter, and Facebook, for authoritative guidance. Perhaps the greatest asset in social capital is that of benevolence. In today’s social networks, the social economy is defined by how people earn and spend social capital. Scarcity – less is more.

Customer 122

Customer Custom Social Media Technical Review 122

From the Venture Trenches

APRIL 19, 2013

Henry Blodget , was once the darling of Wall Street covering Internet securities at Merrill Lynch’s and reporting on businesses such as Infospace, Internet Capital Group and Amazon. In 2002 Blodget’s salary was $12 million. In 2003 Blodget struck a civil settlement deal with the SEC that cost him $4 million.

Blogging 40

Blogging News Journal Invest 40

Startup Professionals Musings

SEPTEMBER 16, 2022

Getting a fixed price bid works for well-defined short-term projects, like blogging or programming. Do your research with peers, and check the alternatives on every project. You will need to invest more in training your own team, and increase your capital budget for new hardware and software. Be flexible.

Outsource Development 138

Outsource Development Outsource Summary Training 138

Xconomy

SEPTEMBER 2, 2020

Research has yielded a crop of gastrointestinal disorder drug. Seattle-based Lumen turns spirulina into tiny factories that churn out therapeutic antibodies. Finrow says the Lumen technology overcomes many of the challenges of working with cyanobacteria. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Research 120

Research Startup Technology San Diego 120

Xconomy

SEPTEMBER 5, 2018

But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital. Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73

Xconomy

OCTOBER 8, 2019

Scientists, no matter how sexy the research they’re conducting, aren’t immune from the administrative minutiae of office life. Such tasks steal time away from researchers’ main objectives. However, that wasn’t the problem San Diego startup LabFellows was looking to solve when it launched in 2014.

San Diego 112

San Diego Research Startup Help 112

Xconomy

SEPTEMBER 23, 2019

Ivan Liachko turned postdoctoral research at the University of Washington into a company whose genomics tools are now found in laboratories researching human, animal, and plant health. His firm, Phase Genomics was one of the first startups to come out of UW’s genome sciences department. Some technologies developed in UW labs.

Incubator 111

Incubator Research Tool Startup 111

Xconomy

JUNE 19, 2019

San Diego’s Element Biosciences said Tuesday that it had secured a Series A round led by Foresite Capital, a healthcare and life sciences venture capital firm based in San Francisco, and Silicon Valley’s Venrock. Prior to joining the firm in 2017, she was a senior director of scientific research.

Tool 67

Tool Develop Development Venture Capital 67

Xconomy

DECEMBER 26, 2018

The sector saw more big venture capital deals and acquisitions , while researchers kept plugging away on technology advances. It was an eventful year for the artificial intelligence industry. Meanwhile, A.I. developers continued to grapple with issues around transparency, trust, and ethics.

Artificial Inteligence 94

Artificial Inteligence Venture Capital Research Acquisition 94

Xconomy

NOVEMBER 8, 2017

Peter Lee is the Microsoft Research executive in charge of the NExT initiative—an effort quietly begun in 2014 by CEO Satya Nadella and Harry Shum, head of the company’s A.I. division, to convert select projects from the company’s global research apparatus into business opportunities.

Artificial Inteligence 75

Artificial Inteligence Research Venture Capital Capital 75

Xconomy

MARCH 20, 2018

We’re recapping them very quickly here, and adding two reaction quotes we received from Carrie Morton, deputy director of the University of Michigan’s Mcity research facility and test bed, and Shahin Farshchi, a partner at Lux Capital, a Silicon Valley venture capital firm that has a number of investments in mobility companies.

Venture Capital 75

Venture Capital Research Mobile Capital 75

SoCal CTO

JANUARY 5, 2012

It always has great, fresh content from a wide variety of industry professionals.

CTO Hire 175

CTO Hire Newsletter Content Sites 175

Xconomy

JUNE 26, 2018

But that is starting to change, as Asian cities—particularly in China—are snapping up more tech venture capital funding and exits, according to a new report from CB Insights. But Beijing and Shanghai startups appear to be working to keep pace, reeling in $72.

Startup 84

Startup Report Venture Capital Research 84

Xconomy

NOVEMBER 29, 2017

Codiak BioSciences, the startup run by former Biogen (NASDAQ: BIIB ) research chief Doug Williams, has rung up its third big round of cash in two years. million Series C round from a large group of investors, among them founding backers Flagship Pioneering and Arch Venture Partners, and new participants EcoR1 Capital and Casdin Capital.

Research 72

Research Capital Startup Company 72

socalTECH

JANUARY 5, 2009

Carroll has also served at Peppers and Rogers Group, Hewlett Packard, and NASA/Ames Research Center. Brickfish operates a service which allows consumers to share videos, blogs, and photos, all tied into brand promotions and ad campaigns. Mangrove Capital Partners, and OCA Ventures.

Social Media 100

Social Media Media Draper San Diego 100

socalTECH

DECEMBER 26, 2018

I met with many deeply talented entrepreneurs, researchers, investors, community organizers and professionals who are thriving in these separate yet overlapping (and interdependent) ecosystems. What was most striking was the diversity and breadth of the node-network that defines the region--so complex and at times, overwhelming.

Southern California 113

Southern California SoCal Pasadena Startup 113

Xconomy

DECEMBER 10, 2018

It’s often difficult for military researchers to find investors who will help them privately commercialize the innovations they develop, in part because the duties of military physicians are different than those of civilian doctors.

Research 111

Research Tool Help Technology 111

Xconomy

JUNE 28, 2018

The Series D round included investments from previous BitSight backers Menlo Ventures, GGV Capital, and Singtel Innov8. The new funding brings BitSight’s total venture capital haul to $155. Read more » Reprints | Share:

Venture Capital 55

Venture Capital Equity Research Capital 55

Xconomy

JANUARY 31, 2020

Black Diamond’s stock price rise shows that investors continue to be interested in companies developing kinase inhibitors for solid tumors, according to IPO research firm Renaissance Capital. That IPO “pop” is also a sign that this year will be an active one for biotech companies going public. Renaissance.

Research 51

Research Pricing Activity Capital 51

Xconomy

JUNE 22, 2016

Agtech investment firm Finistere Ventures; private equity firm Cloud Break Advisors; and Israeli venture capital firm OurCrowd contributed to the new accelerator. But Radicle’s plans more closely resemble the Research Triangle Park-based AgTech Accelerator, which shares an industry partner in Bayer.

Funding 68

Funding Research San Diego Incubator 68

Xconomy

SEPTEMBER 23, 2020

Libra Therapeutics is turning that research into potential therapies, and it now has $29 million to advance its work. Amyotrophic lateral sclerosis (ALS) has no cure and few available treatments but the past decade has revealed new knowledge about the pathology of the disease.

Research 114

Research San Diego Blogging Funding 114

Xconomy

JUNE 28, 2017

Vivace Therapeutics, a San Mateo, CA-based biotech that has kept quiet about its research until now, has reached across the Pacific Ocean to close $25 million in financing to support its work developing drugs to target two different mechanisms of cancer biology. Vivace says Canaan and WuXi led a $15 million Series A round.

Research 56

Research Capital Funding Invest 56

Xconomy

MAY 15, 2017

San Diego’s Scientist.com set out in 2006 to disrupt part of the pharmaceutical business by providing an Amazon-like approach to the business of hiring contract research organizations (CROs). Founding CEO Kevin Lustig said Scientist.com will use the additional cash to expand its operations. Lustig argued.

Outsource 79

Outsource Marketing Research Web 79

Xconomy

MARCH 13, 2018

At Intel Capital in the Bay Area, investment director Ranjeet Alexis is an expert in bioinformatics who is scouting for deals at the intersection of computation, healthcare, and the life sciences. His investments include Synthego , a provider of technology used in CRISPR genome editing and research.

San Diego 67

San Diego Artificial Inteligence Research Invest 67

Both Sides of the Table

MAY 6, 2018

As a VC with scores of startups in our portfolio we have ringside seats to many, many fund raising processes plus I had to raise money across about 5 different rounds of capital as an entrepreneur so I’ve developed some thought on the process that I hope can be helpful to some of you before you start. just don’t lead with them!

Funding 236

Funding Venture Capital Startup Entrepreneur 236

Xconomy

MARCH 19, 2020

Three hundred Takeda employees from the Japanese pharma giant’s California research center have been working from home for 10 days straight. Neurocrine Biosciences, one of the few commercial-stage biotechs in town, is working to ensure the animals housed in its vivarium are appropriately minded.

San Diego 120

San Diego Research Develop Development 120

Both Sides of the Table

OCTOBER 26, 2014

Contrary to popular opinion I actually believe crowd-funding is best used after seed capital or venture capital. Obviously you should have somebody that helps you research journalists, gets you meetings, pitches stories, helps prep you for interviews & helps make sure your writing is cogent. Just don’t spam people.

Press 319

Press Startup Writing Training 319

Both Sides of the Table

APRIL 13, 2011

Brad on blogging. How did you start blogging? “My My initial desire to blog came from something that’s always been my approach to investing – I’m a nerd and I love to play with the technology and part of my approach has really been to understand things both at a user level and at a reasonably deep tentacle level. was starting.

Venture Capital 288

Venture Capital Startup Technical Review Software Review 288

Xconomy

MAY 21, 2019

These days, Thrun seems just as excited by another imprint he’s made on the still-forming AV industry—not as a researcher, but as an entrepreneur in online education.

Education 87

Education Software Engineering Training Research 87